5,10,15,20—四（3—溴—4—磺酸苯基）卟啉光度法测定痕量铜的研究

本文研究了新水溶剂卟啉试剂５，１０，１５，２０－四（３－溴－４－磺酸苯基）卟啉（Ｔ（３－ＢｒＰ）ＰＳ４）与铜的显色反应，在ｐＨ３，铜与５，１０，１５，２０－四（３－溴－４－磺酸苯基）卟啉形成１：１的稳定配合物，此配合物的最大吸收波长位于４１２．８ｎｍ摩尔吸光系数为２．６１×１０＾５Ｌ．ｍｏｌ＾－１．ｃｍ＾－１。铜量在０～３．０μｇ／２５ｍＬ范围内符合比尔定律，工作曲线回归方程为ｙ＝ ０．００９４３     

SLS存在下meso-四(对三甲胺基苯基)卟啉测定微量铜

研究了表面活性剂十二烷基苯磺酸钠存在时,ｍｅｓｏ－四（对三甲基苯基）卟啉「Ｔ（４－ＴＭＡＰ）Ｐ」与铜的显色反应。在ｐＨ＝３．７的ＨＡｃ－ＮＡａｃ介质中,在ＳＬＳ眄,铜与「Ｔ（４－ＴＭＡＰ）Ｐ」形成１：２的稳定配合物,至少在４．５ｈ内吸光度无变化。最大吸收波长位于４１０ｎｍ,ε＝３．７９×１０＾５Ｌ．ｍｏｌ＾０－１．ｃｍ＾－１。     

5，10，15，20－四（3－溴－4－磺酸苯基）卟啉光度法测定痕量铜的研究

本文研究了新水溶性卟啉试剂５，１０，１５，２０－四（３－溴－４－磺酸苯基）卟啉［Ｔ（３－ＢｒＰ）ＰＳ＿４与铜的显色反应。在ｐＨ３，铜与５，１０，１５，２０－四（３－溴－４－磺酸苯基）卟啉形成１：１的稳定配合物。此配合物的最大吸收波长位于４１２．８ｎｍ，摩尔吸光系数为２．６１×１０￣５Ｌ·ｍｏｌ￣（－１）·ｃｍ￣（－１）。铜量在０～３．０μｇ／２５ｍＬ范围内符合比尔定律，工作曲线回归方程为ｙ＝０．００９４３、＋０．１６７ｘ，相关系数为ｒ＝０．９９９７。方法有较高的灵敏度和较好的选择性，直接用于大米和茶叶中痕量铜的测定，结果与ＡＡＳ法一致。     

5，10，15，20－四（3－溴－4－磺酸苯基）卟啉光度法测定痕量锌的研究

本文研究了新水溶性卟啉试剂５，１０，１５，２０－四（３－溴－４－磺酸苯基）卟啉［Ｔ（３－ＢｒＰ）ＰＳ４］与锌的显色反应。在ｐＨ４，锌与５，１０，１５，２０－四（３－溴－４－磺酸苯基）卟啉形成稳定的１：１配合物，其最大吸收波长位于４２２．０ｎｍ，摩尔吸光系数为３．９×１０５Ｌ·ｍｏｌ（－１）·ｃｍ（－１）。锌量在０～２．５μｇ／２５ｍＬ范围符合比尔定律。方法具有较高的灵敏度和较好的选择性，用于人发和大米中痕量锌的测定，结果与原子吸收法一致。     

3,3′,5,5′—四甲基联苯胺吸光光度法测定水中NO2^——N

提出用３,３′,５－５′－四甲基联苯胺（ＴＭＢ）吸光光度法测定水中ＮＯ２＾－－Ｎ。在ＨＯＡｃ－ＮａＯＡｃ缓冲液（ｐＨ３．６）中,ＴＭＢ与ＮＯ２＾－反应生成蓝色的ＴＭＢ－ＴＭＢ亚胺传荷络合物,其最大吸收波长为６５０ｎｍ,表观摩尔吸光系数为２．５９×１０＾４,ＮＯ２＾－－Ｎ与０～０．５μｇ·ｍｌ＾－１范围内服从比耳定律。运用此法测定了环境水样并进行了加标回收试验,结果满意。     

Meso—四—（3,5—二溴—4—羟基苯）卟啉分光光度测定食品中微量铅

研究了溴代卟啉试剂（ＤＢＨＰ）Ｐ分光光度法测定食品中微量铅。在０．０８ｍｏｌ／ＬＮａＯＨ介质中,铅与Ｔ（ＤＢＨＰ）Ｐ反应生成一橙黄色配合物,λｍａｘ＝４７９ｎｍ,ε＝２．２×１０＾５Ｌ·ｍｏｌ＾－１·ｃｍ＾－１。铅在０－１２μｇ／２５ｍＬ范围内符合比耳定律,用于食品中微量铅的测定,获得满意结果。     

3,5—Br2—PADAP—IO^—30SCN—三元离子缔合物测定微量IO^— …

研究了３，５－Ｂｒ２－ＰＡＤＡＰ在酸性介质中质子化，与ＩＯ＾－３和ＳＣＮ＾－形成三元离子缔合物的最佳条件，其表现摩尔吸光系数为１．４＊１０＾５Ｌ．ｍｏｌ＾－１．ｃｍ＾－１，缔合物组成比为３，５－Ｂｒ２－ＰＡＤＡＰ：ＩＯ＾３：ＳＣＮ＾－＝１：１：１。     

Fe（Ⅲ）—TEA—5—Br—PADAP—H2O2体系中催化波的研究及其应用

在０．２ｍｏｌ·Ｌ＾－１ＮＨ４Ｃｌ－ＮＨ３·Ｈ２Ｏ底液中，（ｐＨ为９．２６），得到一个极为灵敏的Ｆｅ（Ⅲ）－ＴＥＡ－５－Ｂｒ－ＰＡＤＡＰ－Ｈ２Ｏ２配合吸附催化波，其峰电位为－０．７１Ｖ（ｖｓ．ＳＣＥ）。铁浓度在１．８×１０＾－１０￣５．４×１０＾－６ｍｏｌ·Ｌ＾－１范围内与二阶导数波高呈线性关系。对该极谱波的性质进行了研究，证明是一种配合吸附催化波，并成功地应用于各类水样，钒催化剂中微量或痕量铁的     

邻菲啰啉和过氧化氢对锰－卟啉显色反应的影响

本文研究了在邻菲啰啉，过氧化氢存在下，Ｔ（４－ＭＰ）ＰＳ＿４、ＴＰＰＳ＿４、Ｔ（４－ＭＯＰ）ＰＳ＿４、Ｔ（４－ＨＰ）ＰＳ＿４、Ｔ（３－ＣＩＰ）ＰＳ＿４、Ｔ（３－ＢｒＰ）ＰＳ＿４等六种卟啉试剂与锰的显色反应。结果表明，当溶液ｐＨ为９．１５～９．３５时，邻菲啉和过氧化氢对锰与卟啉试剂显色反应协同增敏作用显著。加入表面活性剂ＣＴＭＡＢ，增强了配合物的稳定性和灵敏度。表观摩尔吸光系数高达１０￣７Ｌ·ｍｏｌ￣（－１）·ｃｍ￣（－１）。本法用于测定食品中的痕量锰，结果满意。     

反相高效液相色谱法半制备分离[T(4-MOP)PS4]卟啉的研究

本文研究了新水溶性５，１０，１５，２０－四（４－甲氧基－３－磺酸苯基）卟啉［Ｔ（４－ＭＯＰ）ＰＳ４］的反相高效液相色谱（ＨＰＬＣ）分离条件。采用ＳｈｉｍｐａｃｋＰＲＥＰ－ＯＤＳ半制备色谱柱，用含有１０ｍｍｏｌ／Ｌ四乙基碘化铵的乙腈－水（体积比２５：７５）为流动相，流速１８ｍＬ／ｍｉｎ，于４１８ｎｍ波长下检测。［Ｔ（４－ＭＯＰ）ＰＳ４］与合成中生成的杂质组分完全分离。经此制备的卟啉纯度高，已成功地应用于自来水样中微量钴、锌、铜离子的ＨＰＬＣ测定中。     

The crystal structure of LaIr4B4, ThOs4B4, ThIr4B4 (NdCo4B4-type) and URu4B4, UOs4B4 (LuRu4B4-type)

The crystal structure of LaIr₄B₄ has been refined from single crystal counter data. LaIr₄B₄ is tetragonal,P4₂/n,Z=2, isotypic with NdCo₄B₄, |F|/|F _o|=0.039 for 312 independent reflections [|F _o|>2 (F _o)]. ThIr₄B₄ and ThOs₄B₄ also belong to the NdCo₄B₄-type structure. URu₄B₄ and UOs₄B₄ were found to crystallize with LuRu₄B₄-type structure. The crystal chemistry of (RE)T ₄B₄-phases is discussed and simple geometric relations are shown to exist between them.Dedicated to Prof.B. T. Matthias in celebration of his 60th birthday.     

4-巯基-4-脱氧-4'-去甲表鬼臼毒素的立体控制合成

4-巯基-4-脱氧-4'-去甲表鬼臼毒素是合成4位硫取代的4'-去甲表鬼臼毒素的关键中间体,由4'-去甲表鬼臼毒素与硫化氢在BF~3·Et~2O存在下立体控制制备,也可通过以NH~3/CH~CN选择性 地水解4-乙酰硫基-4-脱氧-4'-去甲表鬼臼毒素而制备.     

Electronic structures of the boron cage molecules B4H4, B4Cl4 and B4F4

Ab initio calculations have been performed on B₄H₄, B₄Cl₄ and B₄F₄ in order to aid our understanding of the bonding in these compounds, which is presumably based on a tetrahedral boron cage. This cage has only 8 electrons and so is less than that expected on the basis of the usual framework electron counting rules. Basis sets with polarisation functions were used at the SCF, CI and CPF levels of theory to confirm that the T _d structures are indeed more stable than the D _4h ones. Davidson-Roby population analyses were able to show that many factors, including 3-centre 2-electron bonding and backbonding from the ligand to the boron cage, are of importance in determining the relative stability of the three compounds, of which B₄Cl₄ is the only one that has yet been observed experimentally.     

Synthesis of 4-alkoxy-4-methyl- and 4-alkoxy-4-fluoromethyl-1,3-benzoxazinones

Cyclization of 2-hydroxyacetophenone hydrazones with triphosgene resulted in the formation of 4-methylene-1,3-benzoxazinones. These compounds were converted to 4-alkoxy-4-methyl-1,3-benzoxazinones and 4-fluoromethyl-4-methoxy-1,3-benzoxazinones upon treatment with alcohols under refluxing conditions and F-TEDA-BF₄ in acetonitrile and methanol, respectively.     

Smectic polymorphism of the 4-butyl-4-alkoxyazobenzenes and 4-pentyl-4-alkoxyazobenzenes

Two families of liquid crystalline compounds have been synthesised, the 4-butyl-4- alkoxyazobenzenes and the 4-pentyl-4-alkoxyazobenzenes; for the second family results are presented for the first time for alkoxy chains longer than butyl. The results for both families have been obtained up to the octadecyl homologues. In both families, on the basis of DSC, polarizing microscopy and thermo-optical analysis, a rich polymorphism has been detected (maximum tetramorphism). The smectic properties start with the hexyl derivative (for the butyl family) and with the heptyl derivative (for the pentyl family). Strong odd-even effects for the temperatures of clearing in both groups of compounds were detected. Our results are compared with those of de Jeu et al. and of Adomenas et al. for the 4-butyl-4- alkoxyazobenzenes, for which only one smectic modification was described.     

Fluorination of 4-nitroisoxazoline salts. Synthesis of 4-fluoro-4-nitroisoxazolines and 4-fluoroisoxazoles

Methods for the synthesis of hitherto unknown 4-fluoro-4-nitroisoxazolines by fluorination of 4-nitroisoxazoline salts with FClO₃ in MeOH and 4-fluoroisoxazoles by treatment of fluoronitroisoxazolines bearing the hydrogen atom bound to the C(5) atom of the isoxazole ring with MeONa in MeOH were developed.     

Synthesis of 4H-pyrazolo- and 4H-pyrrolophenothiazin-4-one derivatives

5-Methyl- and 6-methyl-2-phenyl-2H-indazole-4,7-diones were condensed with 2-aminobenzenethiol or 6-substituted-3-aminopyridine-2(1H)thiones 4 to produce a new type of 5-methyl-2-phenyl-4H-pyrazolophenothiazin-4-ones or 8-substituted-7-aza-5-methyl-2-phenyl-4H-pyrazolophenothiazin-4-one derivatives. From 6-bromo-2,5-dimethyl-1,3-diphenyl-2H-isoindole-4,7-dione and 4 8-substituted-7-aza-2,5-dimethyl-1,3-diphenyl-4H-pyrrolophenothiazin-4-one derivatives were also prepared.